NEC aims to develop cancer drugs using artificial intelligence

NEC Corp. said it will develop cancer drugs using artificial intelligence, aiming to put new vaccines using peptides into practical use within the next eight years as key substances in next generation immunotherapy. A peptide is a short chain of amino acids with an enormous number of variations and helps increase cells that attack cancer. Whether a pattern works depends on the patient’s leukocyte group, so NEC will use its AI technology to quickly choose the right type of peptide, the company said Monday. Under joint research with Yamaguchi and Kochi universities, NEC has already discovered a peptide that the developers hope will be effective for liver cell and esophageal cancer. A new company established for the project, Cytlimic Inc., plans to commercialize effective peptide vaccines in cooperation with pharmaceutical…

Link to Full Article: NEC aims to develop cancer drugs using artificial intelligence

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!